Home » Topics » Regulatory » Patents

Patents
RSS

Immunophage Biomedical presents new CCR8 antagonists

Jan. 24, 2022

Sichuan Haisco Pharmaceutical discloses new JAK inhibitors

Jan. 24, 2022

Chinese researchers patent sigma-1 receptor agonists

Jan. 24, 2022

BioWorld MedTech Patent Highlights: Week 2

From Current Patent Gazette

Jan. 21, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

4E Therapeutics discloses new MNK1 and/or MNK2 inhibitors

Jan. 21, 2022

New three-prime repair exonuclease 1 inhibitors described by Tempest Therapeutics

Jan. 21, 2022

Scripps Research Institute, ShangPharma Innovation patent Rev-erbA-alpha/beta agonists

Jan. 21, 2022

New macrophage migration inhibitory factor inhibitors identified at Immunophage Biomedical

Jan. 21, 2022

New TRPA1 antagonists discovered at Boehringer Ingelheim

Jan. 21, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...